Related Experiment Video
Updated: Aug 13, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
The type 1 (EGFR-related) family of growth factor receptors and their ligands
1Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Abstract:
This review considers the biology of the type 1 growth factor receptor family which is increasingly recognised as important in the control of normal cell proliferation and in the pathogenesis of human cancer. The family currently comprises three closely related members: the epidermal growth factor (EGF) receptor, c-erbB-2 and c-erbB-3, all of which show abnormalities of expression in various human tumours. The family of factors related to EGF has also expanded recently and now includes transforming growth factor alpha, heparin-binding EGF, amphiregulin, cripto and heregulin, as well as several other potential ligands for the c-erbB2-2 receptor. The involvement of these receptors and growth factors in human cancer has implications for the design of novel forms of therapy for cancer, and we review recent advances and future avenues for investigation.
Insights
The type 1 growth factor receptor family, including the epidermal growth factor (EGF) receptor, plays a key role in cell growth and cancer. Understanding these receptors and their ligands is crucial for developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The type 1 growth factor receptor family is critical for normal cell proliferation.
- Aberrant expression of these receptors is implicated in human cancer pathogenesis.
- Recent discoveries have expanded the known ligands for this receptor family.
Purpose of the Study:
- To review the biology of the type 1 growth factor receptor family.
- To discuss the role of these receptors and their ligands in human cancer.
- To explore implications for novel cancer therapy development.
Main Methods:
- Literature review of biological and clinical studies.
- Analysis of receptor-ligand interactions.
- Examination of expression patterns in human tumors.
Main Results:
- The type 1 growth factor receptor family includes EGF receptor, c-erbB-2, and c-erbB-3.
- Abnormalities in receptor expression are observed in various human tumors.
- Expanded list of EGF-related factors and potential ligands for c-erbB2-2.
Conclusions:
- The type 1 growth factor receptor family is a significant target in cancer research.
- Understanding these molecular pathways offers potential for innovative cancer treatments.
- Further investigation into receptor-ligand dynamics is warranted for therapeutic advancements.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

